We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$383B
AUM Growth
+$14.2B
Cap. Flow
-$1.89B
Cap. Flow %
-0.5%
Top 10 Hldgs %
13.31%
Holding
4,419
New
190
Increased
1,733
Reduced
2,081
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$531M
2
KMI icon
Kinder Morgan
KMI
+$496M
3
IBM icon
IBM
IBM
+$253M
4
CA
CA, Inc.
CA
+$213M
5
EL icon
Estee Lauder
EL
+$209M

Sector Composition

Rank Sector Weight
1 Technology 16.01%
2 Financials 13.85%
3 Healthcare 13.68%
4 Industrials 10.26%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRWN
3476
DELISTED
CROWN MEDIA HOLDINGS INC CL-A
CRWN
$566K ﹤0.01%
160,101
+834
+0.5% +$2.83K
VHT icon
3477
Vanguard Health Care ETF
VHT
$19B
$562K ﹤0.01%
4,478
+2,107
+89% +$259K
UFPT icon
3478
UFP Technologies
UFPT
$2.48B
$561K ﹤0.01%
22,836
+1,322
+6% +$29.3K
IMDZ
3479
DELISTED
Immune Design Corp.
IMDZ
$561K ﹤0.01%
18,240
+5,176
+40% +$144K
PSEC icon
3480
Prospect Capital
PSEC
$1.18B
$559K ﹤0.01%
67,672
+20,019
+42% +$185K
ADMS
3481
DELISTED
Adamas Pharmaceuticals
ADMS
$557K ﹤0.01%
+32,095
New +$487K
NFO
3482
DELISTED
Invesco Insider Sentiment ETF
NFO
$557K ﹤0.01%
+11,353
New +$543K
RBCN
3483
DELISTED
Rubicon Technology, Inc.
RBCN
$554K ﹤0.01%
12,133
-5,848
-33% -$257K
SPH icon
3484
Suburban Propane Partners
SPH
$1.17B
$552K ﹤0.01%
12,764
-104,072
-89% -$4.62M
FLNA
3485
Filana Therapeutics
FLNA
$45.7M
$549K ﹤0.01%
38,604
-391
-1% -$6.77K
LSTA icon
3486
Lisata Therapeutics
LSTA
$10.2M
$548K ﹤0.01%
970
-10
-1% -$6.81K
URTH icon
3487
iShares MSCI World ETF
URTH
$8.4B
$548K ﹤0.01%
7,651
+4,657
+156% +$333K
PROV icon
3488
Provident Financial
PROV
$113M
$547K ﹤0.01%
36,124
-17,057
-32% -$253K
DXYN
3489
DELISTED
Dixie Group Inc
DXYN
$545K ﹤0.01%
59,483
-4,507
-7% -$35.7K
XLKS
3490
DELISTED
POWERSHARES S&P SMALLCAP INFORMATION TECHNOLOGY PORTFOLIO
XLKS
$545K ﹤0.01%
10,857
IBCA
3491
DELISTED
INTERVEST BANCSHARES CORP COM
IBCA
$543K ﹤0.01%
54,010
+12,682
+31% +$124K
VIRX
3492
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$542K ﹤0.01%
1,011
-602
-37% -$271K
OXFD
3493
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$542K ﹤0.01%
39,877
-1,045
-3% -$14.3K
CACB
3494
DELISTED
Cascade Bancorp
CACB
$540K ﹤0.01%
104,072
-2,632
-2% -$13.1K
DXM
3495
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$540K ﹤0.01%
60,201
-2,796
-4% -$24K
ECON icon
3496
Columbia Emerging Markets Consumer ETF
ECON
$313M
$536K ﹤0.01%
21,176
+630
+3% +$16.5K
HELI
3497
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$536K ﹤0.01%
5,549
+279
+5% +$40.9K
WLKP icon
3498
Westlake Chemical Partners
WLKP
$764M
$535K ﹤0.01%
+18,446
New +$527K
ATRA icon
3499
Atara Biotherapeutics
ATRA
$76.7M
$534K ﹤0.01%
+798
New +$487K
REM icon
3500
iShares Mortgage Real Estate ETF
REM
$547M
$534K ﹤0.01%
11,401
+1,521
+15% +$74.7K

Similar funds

Bank of New York Mellon's Q4 2014 Portfolio in Review

As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
  • Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
  • Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
  • Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
  • Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
  • Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.